BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28032580)

  • 1. [Assessing identity formation of synthetic cannabinoid products' users - an interpretative phenomenological analysis].
    Pintér JN; Kassai S; Rácz J
    Psychiatr Hung; 2016; 31(4):313-326. PubMed ID: 28032580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
    Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
    Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recovering helpers in the addiction treatment system in Hungary: an interpretative phenomenological analysis].
    Kassai S; Pintér JN; Rácz J
    Psychiatr Hung; 2015; 30(4):372-88. PubMed ID: 26771697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Service-users' experiences of an early intervention in psychosis service: an interpretative phenomenological analysis.
    Harris K; Collinson C; das Nair R
    Psychol Psychother; 2012 Dec; 85(4):456-69. PubMed ID: 23080533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental illness and recovery: an interpretative phenomenological analysis of the experiences of Black African service users in England.
    Tuffour I; Simpson A; Reynolds L
    J Res Nurs; 2019 Mar; 24(1-2):104-118. PubMed ID: 34394513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
    Ralphs R; Williams L; Askew R; Norton A
    Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
    CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fog is lifting; veils of mist come and go: an interpretative phenomenological analysis of the experiences of six women recovering from pathological dissociation.
    Mauritzson M; Bergendahl Odby E; Holmqvist R; Nilsson D
    J Interpers Violence; 2015 Jan; 30(1):45-61. PubMed ID: 24825866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The experience of auditory hallucination and the role of self-help groups: an interpretative phenomenological analysis].
    Kassai S; Kiss M; Pintér JN; Rácz J
    Psychiatr Hung; 2016; 31(1):52-70. PubMed ID: 27091923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What about me? The loss of self through the experience of traumatic childbirth.
    Byrne V; Egan J; Mac Neela P; Sarma K
    Midwifery; 2017 Aug; 51():1-11. PubMed ID: 28494225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interpretative phenomenological analysis of service users' experiences in a psychosocial addictions intervention.
    Dawood R; Done J
    Psychol Psychother; 2021 Jun; 94(2):307-321. PubMed ID: 32725864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. '…it shows that there's no limits': the psychological impact of co-production for experts by experience working in youth mental health.
    Mayer C; McKenzie K
    Health Soc Care Community; 2017 May; 25(3):1181-1189. PubMed ID: 28088845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young women's accounts of intimate partner violence during adolescence and subsequent recovery processes: an interpretative phenomenological analysis.
    Reynolds F; Shepherd C
    Psychol Psychother; 2011 Sep; 84(3):314-34. PubMed ID: 22903872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoid use: a case series of adolescents.
    Castellanos D; Singh S; Thornton G; Avila M; Moreno A
    J Adolesc Health; 2011 Oct; 49(4):347-9. PubMed ID: 21939863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of synthetic cannabinoid use in Australia.
    Barratt MJ; Cakic V; Lenton S
    Drug Alcohol Rev; 2013 Mar; 32(2):141-6. PubMed ID: 23043552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of young adults with type 1 diabetes while using alcohol and recreational drugs: An interpretative phenomenological analysis (IPA) of semi-structured interviews.
    Pastor A; O'Brien CL; Teng J; Conn J; Loh M; Collins L; MacIsaac RJ; Bonomo Y
    Diabetes Res Clin Pract; 2018 Jul; 141():47-55. PubMed ID: 29689319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do clients experience reliving as part of trauma-focused cognitive behavioural therapy for posttraumatic stress disorder?
    Shearing V; Lee D; Clohessy S
    Psychol Psychother; 2011 Dec; 84(4):458-75. PubMed ID: 22903886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of cannabis use in the life experience of men with schizophrenia.
    Wagstaff C; Graham H; Farrell D; Larkin M; Tatham L
    Int J Ment Health Nurs; 2018 Jun; 27(3):1099-1108. PubMed ID: 29218823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.